Overview

Open Label Phase 2 Feasibility Study of BPX-04 Topical Minocycline Gel in Rosacea

Status:
Completed
Trial end date:
2018-06-19
Target enrollment:
Participant gender:
Summary
An open label feasibility study using BPX-04 topical minocycline gel in papulopustular rosacea.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
BioPharmX, Inc.
Treatments:
Minocycline